Cambridge Investment Research Advisors’s iShares iBonds Dec 2028 Term Corporate ETF IBDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.07M Sell
240,359
-1,179
-0.5% -$29.8K 0.01% 913
2026
Q1
$6.12M Buy
241,538
+19,344
+9% +$492K 0.02% 855
2025
Q4
$5.66M Buy
222,194
+25,974
+13% +$662K 0.01% 859
2025
Q3
$5.01M Buy
196,220
+15,956
+9% +$406K 0.01% 916
2025
Q2
$4.58M Buy
180,264
+38,143
+27% +$961K 0.01% 901
2025
Q1
$3.59M Buy
142,121
+37,498
+36% +$940K 0.01% 977
2024
Q4
$2.6M Buy
104,623
+22,325
+27% +$561K 0.01% 1177
2024
Q3
$2.1M Buy
82,298
+19,276
+31% +$486K 0.01% 1310
2024
Q2
$1.56M Buy
63,022
+2,341
+4% +$57.7K 0.01% 1462
2024
Q1
$1.51M Buy
60,681
+12,327
+25% +$307K 0.01% 1451
2023
Q4
$1.21M Sell
48,354
-16,670
-26% -$405K 0.01% 1519
2023
Q3
$1.56M Sell
65,024
-25,151
-28% -$612K 0.01% 1284
2023
Q2
$2.21M Buy
90,175
+10,760
+14% +$266K 0.01% 1111
2023
Q1
$1.98M Buy
79,415
+35,763
+82% +$883K 0.01% 1125
2022
Q4
$1.06M Buy
43,652
+13,236
+44% +$319K 0.01% 1480
2022
Q3
$724K Buy
+30,416
New +$759K ﹤0.01% 1696
2021
Q3
Sell
-15,062
Closed -$435K 3141
2021
Q2
$435K Sell
15,062
-107
-0.7% -$3.06K ﹤0.01% 2164
2021
Q1
$430K Buy
15,169
+2,663
+21% +$77K ﹤0.01% 2006
2020
Q4
$370K Buy
12,506
+1,756
+16% +$51.4K ﹤0.01% 1982
2020
Q3
$313K Sell
10,750
-743
-6% -$21.7K ﹤0.01% 1904
2020
Q2
$331K Sell
11,493
-514
-4% -$14.3K ﹤0.01% 1809
2020
Q1
$315K Buy
12,007
+3,405
+40% +$94.1K ﹤0.01% 1652
2019
Q4
$239K Buy
8,602
+1,293
+18% +$35.8K ﹤0.01% 2083
2019
Q3
$203K Buy
+7,309
New +$201K ﹤0.01% 2110

Other funds holding IBDT

Cambridge Investment Research Advisors's IBDT Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its iShares iBonds Dec 2028 Term Corporate ETF (IBDT) stake by 0.49% in Q2 2026, selling an estimated $29.8K and leaving 240,359 shares worth $6.07M. The position accounts for 0.01% of the portfolio, ranked #913.

Cambridge Investment Research Advisors first reported a position in IBDT in Q3 2019 and has held it in 24 quarters since. The position peaked at $6.12M in Q1 2026. 435 funds tracked by Wall St. Rank hold IBDT as of Q2 2026.

  • Cambridge Investment Research Advisors held 240,359 shares of iShares iBonds Dec 2028 Term Corporate ETF worth $6.07M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 1,179 iShares iBonds Dec 2028 Term Corporate ETF shares in Q2 2026, an estimated $29.8K.
  • iShares iBonds Dec 2028 Term Corporate ETF made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #913 holding.
  • Cambridge Investment Research Advisors first reported a position in iShares iBonds Dec 2028 Term Corporate ETF in Q3 2019 and has held it in 24 quarters since.
  • Cambridge Investment Research Advisors's iShares iBonds Dec 2028 Term Corporate ETF position peaked at $6.12M in Q1 2026.
  • 435 funds tracked by Wall St. Rank held iShares iBonds Dec 2028 Term Corporate ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.